Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Vogelmeier (Marburg, Germany), K. Kostikas (Basel, Switzerland), J. Fang (East Hanover, United States of America), B. Jones (Cardiff, United Kingdom), C. Morgan (Cardiff, United Kingdom), R. Fogel (East Hanover, United States of America), F. Gutzwiller (Basel, Switzerland), H. Cao (East Hanover, United States of America). Characterisation of UK and US COPD populations in reference to exacerbation frequency and blood eosinophils level. 1080

Member's Comments

No comment yet.

Related content which might interest you: Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Lack of seasonal variability of blood eosinophil counts in COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016 Stability of blood eosinophils over time in patients with asthma Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 Treatment of COPD exacerbations is able to influence the mononuclear cells level of the peripheral blood Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 The relationship between blood eosinophils and bacterial load in COPD patients Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 T-regulatory cells blood content in patients with asthma exacerbation Source: Annual Congress 2011 - T-cell subsets Year: 2011 Peripheral blood eosinophil counts in COPD patients and its relationship with prescription of inhaled corticosteroid in real world setting in Japan. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Associations between blood eosinophils and decline in lung function among adults with and without asthma Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017 Year: 2018 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Impact of the eosinophil variability on severe exacerbations in an asthmatic population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020 Clinical analysis of acute exacerbation of COPD cases with increased eosinophilic granulocytes in peripheral blood Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Relationship of blood eosinophil count to exacerbations in COPD Source: International Congress 2016 – Airway response to infection Year: 2016 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Blood eosinophils and exacerbation rate in COPD patients over three years Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002